OpenEye Scientific develops molecular modeling software and provides consulting services for drug discovery. The company focuses on computational molecular design and offers a range of tools for biopharmaceutical research.

OpenEye Scientific

Iktos leverages AI and robotics to transform drug discovery, integrating Generative AI with automated synthesis and testing to accelerate development of new treatments.

Iktos

Phasecraft is a quantum computing software company that focuses on developing algorithms and software for quantum computers.

John Morton

Toby Cubitt

Simone Severini

Ashley Montanaro

Phasecraft

PostEra is focused on advancing drug discovery through machine learning, aiming to improve the Design-Make-Test cycle of Medicinal Chemistry and deliver more cures to patients.

PostEra

Software Development

Cadence Design Systems

OpenEye, Cadence Molecular Sciences | 9,817 followers on LinkedIn. OpenEye, Cadence Molecular Sciences is an industry leader in computational molecular design based on decades of delivering rapid, robust, and scalable software, toolkits, and technology and design services across the drug discovery process. Our scientific approach has focused on visualizing and analyzing the shape and electrostatics of molecular 3D structures to inform and guide the advancement of pharmaceuticals and biotechnology. 

OpenEye recently integrated its applications and toolkits into Orion, the only cloud-native, fully integrated molecular design platform.

Sales and Partnerships

Fred Livingston

Jeff Grandy

Bethany W. Gates

Sr Application Scientist Manager at OpenEye, Cadence Molecular Sciences

Eric Arnoult

OpenEye, Cadence Molecular Sciences

Join us at our next webinar on November 21st, 2024 where we’ll explore the capabilities of Orion®, OpenEye’s cloud-native modeling platform. The webinar will include a high-level overview of Orion's functionality and insights into advanced methods like cryptic pocket detection and non-equilibrium switching for relative binding free energy calculations Don’t miss this chance to see how Orion is redefining the drug discovery process!

We’re excited to share that Fortune and Great Place To Work US have named Cadence one of the World’s Best Workplaces, ranking #9 for 2024! 🎉 Huge thanks to our amazing global teams for making this happen! Together, we’re building an inspiring workplace where everyone thrives. Let’s keep the momentum going! 🌟 https://ow.ly/Og5C50U7zCj #WeAreCadence #WorldsBestWorkplaces

Yesterday's miniCUP Boston event brought together scientists, industry leaders, and researchers to discuss the latest advancements in computational chemistry and molecular modeling. Attendees learned about the latest advances from OpenEye and networked with other scientists. Thank you to everyone who attended!

Hot off the press! Cryptic pockets have the potential to open new therapeutic opportunities by revealing ligand binding sites that remain hidden in static apo structures of a target protein. To uncover these cryptic pockets, OpenEye’s scientists applied Weighted Ensemble path sampling to enhance protein motion along normal modes, and then used a combination of analysis methods—Exposon Analysis, Probe Map, and Dynamic Probe Binding—to successfully identify cryptic pockets on the G12D isoform of the KRAS oncoprotein. Now available as Articles ASAP on JCIM. Neha Vithani , She Zhang , Jeff Thompson , Lara Patel , Alexander Demidov , Junchao Xia , Alexander Balaeff , Ahmet Mentes, PhD , Yelena Arnautova , Anna Kohlmann , David Lawson , Anthony Nicholls , Geoff Skillman and David LeBard Cadence Design Systems

There is still time to register for miniCUP Boston this week!

Boost Your Career in Computational Drug Discovery! 🚀 Learn core concepts in Lead Optimization. Looking to enhance your knowledge of key concepts in computational drug discovery? Want practical insights on finding and optimizing drug candidates? Join us for “Essentials of Computational Drug Discovery” - a new four-part lecture series presented by expert scientists at OpenEye —all at no cost to you! 📅 Tues Nov 12, 2024 - Lecture 3: Essentials of Affinity Prediction in Lead Optimization Register now and secure your spot! Cadence Design Systems

We’re excited to attend the 18th German Conference on Cheminformatics from Nov. 3-6, 2024 in Bad Soden am Taunus, Germany. This event brings together experts in cheminformatics, computational chemistry, and drug discovery, and we're thrilled to join the discussion.

In Tokyo? Join us at the Japan Chem-Bio Informatics Society 2024 conference for robust scientific discussions and poster sessions from October 29th-31st. #CBI2024

Register to join our upcoming miniWEBINAR on October 31st to hear from Kalistyn Burley , PhD - Application Scientist II at OpenEye, Cadence Molecular Sciences, presenting on Comparing binding sites with SiteHopper.

According to Christian Cortis - "One of the most important skills you can develop, that you will never be taught... is how to tell stories". At CUP this year Christian and Anthony Nicholls discussed how telling stories is an important business skill. Watch the entire conversation here: https://lnkd.in/gsauJZye

Metric
Company Name	OpenEye Scientific	Iktos	Phasecraft	PostEra
Symbol
MSH ID	COM:EYESOPEN	AI:IKTOS	IO:PHASECRAFT	AI:POSTERA
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Information Technology	Healthcare & Health Services
Industry	Biotechnology	Pharmaceuticals	Technology	Biotechnology
Country	US	FR	GB	US
Stage
Employee Count			27
Website	eyesopen.com	iktos.ai	phasecraft.io	postera.ai
LinkedIn	openeye-scientific-software		phasecraft
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	43
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

EYES

COM:EYESOPEN

OpenEye Scientific

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue